BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7004797)

  • 1. Combined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagon.
    Meretoja OA; Allonen H; Arola M; Laaksonen VO
    Chest; 1980 Dec; 78(6):810-5. PubMed ID: 7004797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction.
    Silke B; Nelson GI; Ahuja RC; Walker C; Taylor SH
    Int J Cardiol; 1984 Mar; 5(3):317-25. PubMed ID: 6706437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J; Feldman RL; Marx JD; Kelly GA
    Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
    Koch G
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
    Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
    Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic effects of labetalol in severe hypertension.
    Omvik P; Lund-Johansen P
    J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hemodynamic effects of intravenous labetalol for postoperative hypertension.
    Orlowski JP; Vidt DG; Walker S; Haluska JF
    Cleve Clin J Med; 1989; 56(1):29-34. PubMed ID: 2731325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
    Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
    J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V; Rieder W; Zierski J; Hempelmann G
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha- and beta-blockade with labetalol in acute myocardial infarction.
    Nelson GI; Ahuja RC; Hussain M; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1982; 4(6):921-4. PubMed ID: 6185783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients.
    Koch G
    Am Heart J; 1977 May; 93(5):585-91. PubMed ID: 851058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
    Koch G
    Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transesophageal echocardiographic assessment of left ventricular function in response to labetalol for control of postoperative hypertension.
    Le Bret F; Coriat P; Gosgnach M; Baron JF; Reiz S; Viars P
    J Cardiothorac Vasc Anesth; 1992 Aug; 6(4):433-7. PubMed ID: 1498298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic dose-response effects of intravenous labetalol in acute myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():98-103. PubMed ID: 6647215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
    Koch G; Fransson L
    Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.